Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-11-03
1994-11-22
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514405, 514248, 541235, 5483631, 540500, C07D48704, A61K 3150, A61K 31415
Patent
active
053669738
ABSTRACT:
The present invention relates to certain novel mercaptoacetylamido pyridazo[1,2]pyridazine, pyrazolo[1,2]pyridazine, pyridazo[1,2- a] [1,2]diazepine and pyrazolo[1,2- a ][1,2]diazepine derivatives useful as inhibitors of enkephalinase and of ACE.
REFERENCES:
patent: 3334091 (1967-07-01), Houlihan
patent: 3334095 (1967-08-01), Houluhan
patent: 4080449 (1978-03-01), Croisier et al.
patent: 4320057 (1982-03-01), Freed et al.
patent: 4391752 (1983-07-01), Crossley
patent: 4399136 (1983-08-01), Hassell et al.
patent: 4415496 (1983-11-01), Harris et al.
patent: 4487929 (1984-12-01), Hassell et al.
patent: 4512924 (1985-04-01), Attwood et al.
patent: 4584294 (1986-04-01), Ruyle
patent: 4658024 (1987-04-01), Attwood et al.
patent: 4692438 (1987-09-01), Hassall et al.
patent: 4716232 (1987-12-01), Ternansky
patent: 4734504 (1988-03-01), Holmes
patent: 4734505 (1988-03-01), Holmes
patent: 4762924 (1988-08-01), Hassall et al.
patent: 4772701 (1988-09-01), Attwood et al.
patent: 4782149 (1988-11-01), Lawton et al.
patent: 4785093 (1988-11-01), Hassell et al.
patent: 4808713 (1989-02-01), Attwood et al.
patent: 4824832 (1989-04-01), Flynn et al.
patent: 4826980 (1989-05-01), Hassell et al.
patent: 4973585 (1990-11-01), Flynn et al.
patent: 5208230 (1993-05-01), Flynn et al.
Fournie-Zaluski, Marie-Claude et al., J. Med. Chem., 1992 vol. 35, pp. 2473-2481.
Fournie-Zaluski, Marie-Claude et al., J. Med. Chem., 1992 vol. 35, pp. 1259-1266.
French, John F., Jour. of Pharm and Exper. Therapeutics, vol. 268, No. 1, pp. 180-186.
W. H. Parsons et al. Biochemical and Biophysical Research Communications vol. 117, No. 1, 1993 (Nov. 30, 1983).
Burkholder, et al. Bioorganic and Medical Chem. Letters, vol. 3, No. 2, pp. 231-234, 1993.
Flynn et al., J. Med. Chem. 1993, 36 2420-2423.
Flynn, et al., J. Am Chem. Soc. 109, 7914 (1987).
Flynn, et al., Peptide Chemistry (1987); T. Shiba & Sakakibara (ed.), Protein Research Foundation, Osaka (1988).
Flynn, et al., Tetrahedron Letters, vol. 31, (6), 815-88 (1990).
Attwood, et al., J. Chem. Soc. Perkin Trans. I, pp. 1011-1019 (1986).
Natoff, et al., Drugs of the Future, vol. 12 (5): 475-483 (1987).
Journal of Am. Coll. of Card. vol. 17, No. 6, pp. 137B-142B (May 1991).
Supplement I Cir. vol. 86(4) pp. 1-220(0873) (Oct. 1992).
J. Med. Chem. (1992), 35, 823-832, Timothy D. Ocain et al.
Bioorganic and Medical Chem. Letters vol. 1, 309, (1991).
Flynn Gary A.
Shum Patrick W.
Barney Charlotte L.
Ford John M.
Merrell Dow Pharmaceuticals Inc.
LandOfFree
Mercaptoacetylamido pyridazo [1,2]pyridazine, pyrazolo[1,2]pyrid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mercaptoacetylamido pyridazo [1,2]pyridazine, pyrazolo[1,2]pyrid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mercaptoacetylamido pyridazo [1,2]pyridazine, pyrazolo[1,2]pyrid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1991582